Health Care Costs and Thromboembolic Events in Hydroxyurea-Treated Patients with Polycythemia Vera

BACKGROUND: Patients with polycythemia vera (PV) are at increased risk of thromboembolic events (TEs), which are key contributors to reduced overall survival compared with the age- and sex-matched general population. In addition to aspirin and phlebotomy to maintain hematocrit level < 45%, many p...

Descripción completa

Detalles Bibliográficos
Autores principales: Parasuraman, Shreekant V., Shi, Nianwen, Paranagama, Dilan C., Bonafede, Machaon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397887/
https://www.ncbi.nlm.nih.gov/pubmed/29290171
http://dx.doi.org/10.18553/jmcp.2018.24.1.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397887/
https://www.ncbi.nlm.nih.gov/pubmed/29290171
http://dx.doi.org/10.18553/jmcp.2018.24.1.47

Ejemplares similares